Outset Tablo is FDA-approved for Home Hemodialysis
Last week, the FDA expanded approval of the Tablo hemodialysis machine to home use—just in time to offer a new option for COVID-19 related challenges. The intuitive, easy to learn system requires little set-up time. Outset’s next step will be a controlled rollout at select sites.
Read the full article » | Posted 04-13-2020
Related Articles
- ETC Model Structure Did Not Move the Needle on Home Dialysis with Social Risk Factors Posted 07-12-2024
- FDA Class I Recalls of Dialysis Products for Potential Risk of Serious Injury or Death Posted 05-09-2024
- New Partnership Will Bring Tablo to 33 States Where US Renal Care has Clinics Posted 05-09-2024
- Tablo-maker Outset Joined the ANNA’s Partnership Advisory Council Posted 05-09-2024